Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US studies bolster CryoLife in knee implant case:

This article was originally published in Clinica

Executive Summary

US studies released last week by the Centers for Disease Control and Prevention (CDC) and the FDA have served to exonerate Atlanta, Georgia-based CryoLife from any possible involvement in the Minnesota knee implant death. Last month, a small cluster of knee implant deaths aroused concern that a common casual link was to blame. In the event, only one patient had been implanted with a CryoLife product. It transpired, as anticipated by CryoLife, that Clostridium sordellii, a rare bacterial infection, was the cause of the death. CryoLife worked with the agencies to identify the cause. Following the findings, the US agencies have decided that no changes to CryoLife's human tissue processing protocols are necessary.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts